Related Experiment Videos

[Relationship between methimazole and antineutrophil cytoplasmic antibody-positive vasculitis]

Lin-qi Chen1, Xue-lan Zhang, Hai-ying Wu

  • 1Children's Hospital Affiliated to Suzhou University, Suzhou 215000, China.

Zhonghua Er Ke Za Zhi = Chinese Journal of Pediatrics
|December 23, 2008
PubMed
Abstract

Insights

Methimazole (MMI) may be linked to antineutrophil cytoplasmic antibody (ANCA)-positive vasculitis, a condition that can cause kidney problems. Prompt treatment with immunosuppressors can resolve symptoms, highlighting the importance of monitoring ANCA levels during MMI therapy.

Area of Science:

  • Endocrinology
  • Nephrology
  • Immunology

Context:

  • Graves' disease is commonly treated with methimazole (MMI).
  • Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis is a serious autoimmune condition.
  • The potential link between MMI and ANCA-positive vasculitis requires further investigation.

Purpose:

  • To investigate the association between methimazole (MMI) and the development of antineutrophil cytoplasmic antibody (ANCA)-positive vasculitis.
  • To analyze clinical and pathological data of patients experiencing ANCA-positive vasculitis during MMI treatment.

Summary:

  • Thirty-three Graves' disease patients were monitored for serum ANCA before and after MMI treatment.
  • Two patients developed ANCA-positive vasculitis with symptoms of hematuria and renal failure after 5-6 years of MMI use.
  • ANCA positivity increased significantly after MMI treatment (9%), with microscopic hematuria being a key finding.

Impact:

  • This study suggests a potential relationship between methimazole and ANCA-positive vasculitis.
  • Renal impairment is a possible complication, emphasizing the need for vigilant monitoring.
  • Effective treatment with immunosuppressors can lead to the resolution of vasculitis symptoms.

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...